Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study

NCT01151098 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
189
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Purdue Pharma LP